Command Palette

Search for a command to run...

Clinical Trials · NCT04531176

EMI-EHP Weight Management and Type 2 Diabetes Pragmatic Trial

TerminatedPhase 4Liraglutide (Prohibited)
Phase
Phase 4
Recruitment status
Terminated
Sponsor
The Cleveland Clinic
Enrollment
74
Start date
Sep 2020
Locations
1 site, United States
Primary endpoint
Mean Change in Body Weight Between Baseline and 12 Months
View Liraglutide compound reference